SCHEMBL2948198

SCHEMBL2948198

COc1cccc(OC)c1C(=O)OCc1cc(O)ccc1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC28A3 Q9HAS3 4/20 0.42
TYMP P19971 1/20 0.42
TYR P14679 1/20 0.41
SLC5A1 P13866 2/20 0.40
ALDH1A1 P00352 2/20 0.39
CA12 O43570 4/20 0.39
CA1 P00915 4/20 0.39
CA2 P00918 4/20 0.39
CA9 Q16790 4/20 0.39
CA4 P22748 2/20 0.38
CA5A P35218 2/20 0.38
CA7 P43166 2/20 0.38
CA13 Q8N1Q1 2/20 0.38
CA14 Q9ULX7 1/20 0.38
CA6 P23280 1/20 0.38
DYRK1A Q13627 1/20 0.38
SNCA P37840 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2962105 0.95 SLC28A3 (0.47) SLC28A3TYMPTYRSLC5A1ALDH1A1
Curculigoside A SCHEMBL29419841 0.89 SLC28A3 (0.55) SLC28A3TYMPTYRSLC5A1DYRK1A
Curculigoside B SCHEMBL29419859 0.84 SLC28A3 (0.60) SLC28A3TYMPTYRSLC5A1DYRK1A
Curculigoside B SCHEMBL7953777 0.84 SLC28A3 (0.60) SLC28A3TYMPTYRSLC5A1DYRK1A
SCHEMBL6405014 0.83 TYR (0.43) SLC28A3TYMPTYRSLC5A1CA12
Salireposide SCHEMBL29891482 0.72 TYMP (0.66) SLC28A3TYMPTYRSLC5A1
SCHEMBL5032807 0.70 SLC5A2 (0.49) SLC28A3TYRSLC5A1
SCHEMBL14975385 0.70 SLC5A2 (0.49) SLC28A3TYRSLC5A1
SCHEMBL30637402 0.69 TYMP (0.55) TYMPTYRSLC5A1
SCHEMBL30637489 0.69 TYMP (0.59) SLC28A3TYMPTYRSLC5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080206162-A1 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses UNIVERSITY OF WASHINGTON 2008-08-28 US claimed
EP-1019044-B1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIV WASHINGTON (US) 2007-04-11 EP claimed
US-20040086585-A1 Composition and methods for treating Alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-05-06 US claimed
US-20040076698-A1 Composition and methods for treating Alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-04-22 US claimed
EP-1019044-A4 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIV WASHINGTON (US) 2004-01-07 EP claimed
US-20010055630-A1 Compostion and methods for treating alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2001-12-27 US claimed
EP-1019044-A1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES University of Washington (US) 2000-07-19 EP claimed
WO-1998051302-A1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIVERSITY OF WASHINGTON (US) 1998-11-19 WO claimed
US-7754250-B2 Composition and methods for treating Alzheimer's disease and other amyloidoses PROTEOTECH, INC. (US) 2010-07-13 US disclosed
US-20080206162-A1 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses UNIVERSITY OF WASHINGTON 2008-08-28 US disclosed
EP-1019044-B1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIV WASHINGTON (US) 2007-04-11 EP disclosed
US-7029710-B2 Methods of isolation of amyloid inhibitory ingredients within Uncaria tomentosa UNIVERSITY OF WASHINGTON (US) 2006-04-18 US disclosed
US-6939570-B1 Composition and methods for treating Alzheimer's disease and other amyloidoses UNIVERSITY OF WASHINGTON (US) 2005-09-06 US disclosed
US-20040086585-A1 Composition and methods for treating Alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-05-06 US disclosed
US-20040076698-A1 Composition and methods for treating Alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-04-22 US disclosed
EP-1019044-A4 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIV WASHINGTON (US) 2004-01-07 EP disclosed
US-6346280-B1 Composition and methods for inhibiting the formation of brain amyloid deposits UNIVERSITY OF WASHINGTON 2002-02-12 US disclosed
US-6264994-B1 Compositions for treating alzheimer's disease and other amyloidoses UNIVERSITY OF WASHINGTON 2001-07-24 US disclosed
EP-1019044-A1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES University of Washington (US) 2000-07-19 EP disclosed
WO-1998051302-A1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIVERSITY OF WASHINGTON (US) 1998-11-19 WO disclosed